The 22nd International Conference on Alzheimer’s Drug Discovery showcases the innovative approaches of Alzheimer’s Drug Discovery Foundation’s (ADDF) funded scientists and their newest results. In addition to featuring ADDF’s portfolio, the program also includes guest presentations focusing on the latest research in the Alzheimer’s disease field.
Dr Dirk beher has been invited to give a lecture on "OGA inhibitors as multimodal drugs for intracellular proteinopathies", on October 4th at 4:45 PM CET (10:45 AM ET). This presentation is part of the session #1 "Clinical Trials and Novel Approaches for Dementia".
The purpose for the annual ADDF conference is to accelerate the development of innovative treatments for Alzheimer’s disease, related dementias and cognitive aging. Attendees will see the diverse cutting-edge approaches ADDF scientists are undertaking and have opportunities for networking and partnership discussions with academic, industry, and foundation thought leaders.
The event will be held online October 4-5, 2021 : further information and program